124 related articles for article (PubMed ID: 21955167)
1. Third-line chemotherapy with tyrosine kinase inhibitor (imatinib mesylate) in recurrent ovarian granulosa cell tumor: case report.
Raspagliesi F; Martinelli F; Grijuela B; Guadalupi V
J Obstet Gynaecol Res; 2011 Dec; 37(12):1864-7. PubMed ID: 21955167
[TBL] [Abstract][Full Text] [Related]
2. Hormonal treatment of a recurrent granulosa cell tumor of the ovary: case report and review of the literature.
Hardy RD; Bell JG; Nicely CJ; Reid GC
Gynecol Oncol; 2005 Mar; 96(3):865-9. PubMed ID: 15721440
[TBL] [Abstract][Full Text] [Related]
3. Expression, mutational analysis and in vitro response of imatinib mesylate and nilotinib target genes in ovarian granulosa cell tumors.
Chu S; Alexiadis M; Fuller PJ
Gynecol Oncol; 2008 Jan; 108(1):182-90. PubMed ID: 18028988
[TBL] [Abstract][Full Text] [Related]
4. Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: a phase II clinical trial.
Krug LM; Crapanzano JP; Azzoli CG; Miller VA; Rizvi N; Gomez J; Kris MG; Pizzo B; Tyson L; Dunne M; Heelan RT
Cancer; 2005 May; 103(10):2128-31. PubMed ID: 15812822
[TBL] [Abstract][Full Text] [Related]
5. Aromatase inhibitors in the treatment of recurrent ovarian granulosa cell tumors: brief report and review of the literature.
Alhilli MM; Long HJ; Podratz KC; Bakkum-Gamez JN
J Obstet Gynaecol Res; 2012 Jan; 38(1):340-4. PubMed ID: 22136798
[TBL] [Abstract][Full Text] [Related]
6. [A case of metastatic gastrointestinal stromal tumor developing a resistance to STI571 (imatinib mesylate)].
Miyake M; Takeda Y; Hasuike Y; Kashiwazaki M; Mishima H; Ikenaga M; Mano M; Takada Y; Hirota S; Tsujinaka T
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1791-4. PubMed ID: 15553717
[TBL] [Abstract][Full Text] [Related]
7. Expression of c-kit and platelet-derived growth factor receptors in ovarian granulosa cell tumors.
Rocconi RP; Matthews KS; Kimball KJ; Conner MG; Baker AC; Barnes MN
Reprod Sci; 2008 Sep; 15(7):673-7. PubMed ID: 18492696
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers.
Coleman RL; Broaddus RR; Bodurka DC; Wolf JK; Burke TW; Kavanagh JJ; Levenback CF; Gershenson DM
Gynecol Oncol; 2006 Apr; 101(1):126-31. PubMed ID: 16271384
[TBL] [Abstract][Full Text] [Related]
9. [A long-term survival case with multiple liver metastases from duodenal gastrointestinal stromal tumor that was drastically reduced by the treatment with imatinib].
Sakakura C; Miyagawa K; Fukuda K; Kin S; Nakase Y; Kuriu Y; Nakashima S; Yoshikawa T; Yamaoka N; Sagara Y; Hagiwara A; Yamagishi H
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1739-41. PubMed ID: 16315926
[TBL] [Abstract][Full Text] [Related]
10. [Peritoneal dissemination from gastrointestinal stromal tumor of small intestine responding completely to imatinib mesylate (STI 571)].
Yamanaka H; Mizushima T; Mikata S; Ito T; Nonaka K; Ide H; Michiura T; Kainuma S; Iwase K
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2125-8. PubMed ID: 16352942
[TBL] [Abstract][Full Text] [Related]
11. The effect of imatinib mesylate (Glivec) on human tumor-derived cells.
Knight LA; Di Nicolantonio F; Whitehouse PA; Mercer SJ; Sharma S; Glaysher S; Hungerford JL; Hurren J; Lamont A; Cree IA
Anticancer Drugs; 2006 Jul; 17(6):649-55. PubMed ID: 16917210
[TBL] [Abstract][Full Text] [Related]
12. The role of imatinib mesylate (Glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-R.
Gross DJ; Munter G; Bitan M; Siegal T; Gabizon A; Weitzen R; Merimsky O; Ackerstein A; Salmon A; Sella A; Slavin S;
Endocr Relat Cancer; 2006 Jun; 13(2):535-40. PubMed ID: 16728580
[TBL] [Abstract][Full Text] [Related]
13. Hematological and molecular response evaluation of CML patients on imatinib.
Gupta A; Prasad K
J Assoc Physicians India; 2007 Feb; 55():109-13. PubMed ID: 17571739
[TBL] [Abstract][Full Text] [Related]
14. Anastrozole therapy in recurrent ovarian adult granulosa cell tumors: a report of 2 cases.
Freeman SA; Modesitt SC
Gynecol Oncol; 2006 Nov; 103(2):755-8. PubMed ID: 16870240
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of patients with gastrointestinal stromal tumour with imatinib mesylate].
Haugland HK; Jebsen NL; Mannelqvist M; Skar R; Eide J; Øvrebø K; Horn A; Jensen DK; Monge OR; Lilleng PK
Tidsskr Nor Laegeforen; 2005 Apr; 125(7):868-72. PubMed ID: 15815732
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of metastatic gastrointestinal stromal tumors with Imatinib: report of four cases].
Garrido S M; Moneada M M; Tapia N G; Méndez O G; Galindo A H; Huete G A; Ibáñez A L; González S; Alvarez Z M
Rev Med Chil; 2007 Oct; 135(10):1327-32. PubMed ID: 18180842
[TBL] [Abstract][Full Text] [Related]
17. GnRH antagonist in the adjuvant treatment of a recurrent ovarian granulosa cell tumor: a case report.
Ameryckx L; Fatemi HM; De Sutter P; Amy JJ
Gynecol Oncol; 2005 Dec; 99(3):764-6. PubMed ID: 16112181
[TBL] [Abstract][Full Text] [Related]
18. Association of intratumoral vascular endothelial growth factor expression and clinical outcome for patients with gastrointestinal stromal tumors treated with imatinib mesylate.
McAuliffe JC; Lazar AJ; Yang D; Steinert DM; Qiao W; Thall PF; Raymond AK; Benjamin RS; Trent JC
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6727-34. PubMed ID: 18006774
[TBL] [Abstract][Full Text] [Related]
19. Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium.
Schmandt RE; Broaddus R; Lu KH; Shvartsman H; Thornton A; Malpica A; Sun C; Bodurka DC; Gershenson DM
Cancer; 2003 Aug; 98(4):758-64. PubMed ID: 12910520
[TBL] [Abstract][Full Text] [Related]
20. Identification of a c-kit exon 8 internal tandem duplication in a feline mast cell tumor case and its favorable response to the tyrosine kinase inhibitor imatinib mesylate.
Isotani M; Tamura K; Yagihara H; Hikosaka M; Ono K; Washizu T; Bonkobara M
Vet Immunol Immunopathol; 2006 Nov; 114(1-2):168-72. PubMed ID: 16908071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
